Recent Price Movement and Market Performance
Hikal’s shares have been under pressure for the past two days, losing 7.18% in that period. Despite a modest weekly gain of 3.99%, the stock has significantly underperformed broader market benchmarks over longer time frames. Year-to-date, the stock has declined by 39.76%, while the Sensex has gained 8.91%. Over the last one year, Hikal’s shares have plunged 46.39%, contrasting sharply with the Sensex’s 4.15% rise. This underperformance extends to a three-year horizon, where the stock has fallen 40.08% against a 36.01% gain in the benchmark index.
On the day of the decline, the stock underperformed its sector by 1.85%, touching an intraday low of ₹232, down 4.29%. Trading volumes were concentrated near the day’s low, signalling selling pressure. Although the stock price remains above its 5-day and 20-day moving averages, it is still below the longer-term 50-day, 100-day, and 200-day averages, indicating a bearish medium-term trend. Investor participation has also waned, with delivery volumes on 05 Dec falling by 63.72% compared to the five-day average, suggesting reduced conviction among buyers.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
Fundamental Weaknesses Weighing on the Stock
Hikal’s recent share price decline is closely linked to its weak financial performance and deteriorating fundamentals. The company reported very negative quarterly results in September 2025, with earnings per share plunging by 320.54%. Its quarterly profit after tax (PAT) stood at a loss of ₹34.90 crore, marking a steep fall compared to the previous four-quarter average. This follows two consecutive quarters of negative results, signalling ongoing operational challenges.
Long-term growth metrics also paint a bleak picture. The company’s operating profits have contracted at a compound annual growth rate (CAGR) of -16.24% over the past five years. Return on equity (ROE) has averaged a modest 8.00%, reflecting low profitability relative to shareholders’ funds. Additionally, the company’s ability to service debt is limited, with a high Debt to EBITDA ratio of 2.51 times. The operating profit to interest coverage ratio for the latest quarter is just 0.48 times, indicating significant financial strain.
Despite an attractive valuation indicated by a return on capital employed (ROCE) of 4.1% and an enterprise value to capital employed ratio of 1.9, these positives are overshadowed by the company’s poor earnings trajectory. Profits have fallen by 86.2% over the past year, which has contributed to the stock’s steep decline. The stock trades at a discount relative to its peers’ historical valuations, but this valuation gap appears justified given the weak fundamentals and negative earnings momentum.
Long-Term Underperformance and Investor Sentiment
Hikal’s stock has consistently underperformed key market indices and sector benchmarks over multiple time frames. Its five-year return of 32.10% lags well behind the Sensex’s 86.59% gain, while its three-year and one-year returns are deeply negative. This sustained underperformance has likely eroded investor confidence, contributing to falling volumes and selling pressure in recent sessions.
Moreover, the majority shareholding by promoters has not translated into improved operational performance or investor sentiment. The combination of weak profitability, high leverage, and disappointing quarterly results has created a challenging environment for the stock.
Why settle for Hikal? SwitchER evaluates this Pharmaceuticals & Biotechnology Smallcap against peers, other sectors, and market caps to find you superior investment opportunities!
- - Comprehensive evaluation done
- - Superior opportunities identified
- - Smart switching enabled
Conclusion
In summary, Hikal Ltd’s recent share price decline is primarily driven by its weak financial results, poor profitability metrics, and deteriorating investor sentiment. Despite some valuation appeal, the company’s negative earnings trend, high debt levels, and sustained underperformance relative to market benchmarks have weighed heavily on the stock. Investors appear cautious amid falling volumes and persistent selling pressure, reflecting concerns over the company’s ability to reverse its current downtrend.
Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →
